Indication
Spinal Cord Tumor
2 clinical trials
2 products
Product
NEO100Clinical trial
An Open Label, Phase 1b Safety, Dose-finding, Brain Tumor Delivery, and Pharmacokinetics Study of Intranasal NEO100 in Patients With Pediatric-type Select Brain TumorsStatus: Not yet recruiting, Estimated PCD: 2024-10-31
Clinical trial
Ideal Imaging Time Point Assessment for Spinal Cord Lesions of Unknown Etiology With FDG PET-MRIStatus: Completed, Estimated PCD: 2024-05-07
Product
Fludeoxyglucose F-18